Current Studies

Endocrinology and Metabolism:

• John Buse , MD
  • A Phase III Randomized, Double Blind, Parallel-Group, Multicenter Study to Compare the Glycemic Effects, Safety and Tolerability of Exenatide Long -Acting Release to Those of Sitaglipin and Poiglitazone in Subjects with Type 2 Diabetes Mellitus Treated with Metformin